Vericel (VCEL) Non-cash Items (2010 - 2014)

Vericel's (VCEL) quarterly Non-cash Items came in at $209375.0 in Q4 2014, up 43.4% year-on-year from $146003.0 in Q4 2013, and down 80.97% quarter-over-quarter from $1.1 million in Q3 2014.

Vericel (VCEL) Non-cash Items (2010 - 2014) Analysis & Trends

Vericel has disclosed Non-cash Items across 5 years of filings, most recently posting $209375.0 for Q4 2014.

  • Non-cash Items for Q4 2014 came in at $209375.0, up 43.4% year-over-year; the trailing twelve-month figure through Dec 2014 was $209375.0 (up 43.4% YoY), and the FY2014 annual result was $209375.0, up 43.4% from the prior year.
  • Non-cash Items came in at $209375.0 for Q4 2014 at Vericel, down from $1.1 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $5.1 million in Q4 2012 to a low of $2750.0 in Q2 2010.
  • The 5-year median for Non-cash Items is $1.6 million (2013), against an average of $2.0 million.
  • Across the five-year window, Non-cash Items soared 662.31% in 2012 and plunged 97.16% in 2013, its largest moves.
  • Vericel's Non-cash Items stood at $3.2 million in 2010, then plunged by 78.66% to $674000.0 in 2011, then jumped by 662.31% to $5.1 million in 2012, then slumped by 97.16% to $146003.0 in 2013, then jumped by 43.4% to $209375.0 in 2014.
  • The last three Non-cash Items figures came in at $209375.0 (Q4 2014), $1.1 million (Q3 2014), and $191888.0 (Q2 2014), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Vericel 2.04 Bn 1.90 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Dec 31, 2014 209,375.00
Dec 31, 2014 209,375.00
Sep 30, 2014 1.10 Mn
Sep 30, 2014 1.10 Mn
Jun 30, 2014 191,888.00
Jun 30, 2014 191,888.00
Mar 31, 2014 179,240.00
Mar 31, 2014 179,240.00
Dec 31, 2013 146,003.00
Dec 31, 2013 146,003.00
Sep 30, 2013 2.16 Mn
Sep 30, 2013 2.16 Mn
Jun 30, 2013 3.06 Mn
Jun 30, 2013 3.06 Mn
Mar 31, 2013 4.96 Mn
Mar 31, 2013 4.96 Mn
Dec 31, 2012 5.14 Mn
Dec 31, 2012 5.14 Mn
Sep 30, 2012 3.73 Mn
Sep 30, 2012 3.73 Mn